Review of GP consultation fees brought to DPM, says Health Minister
KUALA LUMPUR: The review of consultation fees for private general practitioners (GPs) has been raised to a task force chaired by Datuk Seri Ahmad Zahid Hamidi, says Health Minister Datuk Seri Dr Dzulkefly Ahmad.
Dr Dzulkefly stated that after a meeting between the Health Ministry and the National Action Council on Cost of Living (NACCOL), it was decided to escalate the issue to the executive task force led by the Deputy Prime Minister.
'We will bring it up for further details,' said Dr Dzulkefly to reporters after attending the opening ceremony of the 31st Association of Private Hospitals Malaysia (APHM) conference at the KL Convention Centre on Monday (June 9).
Dr Dzulkefly also mentioned there is no deadline for finalising the review of consultation fees for private GPs.
'No, but at the soonest time possible, we will raise this issue.The Deputy Prime Minister, who chairs the executive task force, will look into the final touches of this,' said Dr Dzulkefly.
On May 3, Dr Dzulkefly said the review of consultation fees for private GPs would be finalised within a month.
The Medical Practitioners Coalition Association of Malaysia (MPCAM) proposed on Monday (June 9) to raise private GP fees to a range of RM50 to RM80.
MPCAM noted that GP consultation fees have remained at RM10 to RM35 for more than three decades since 1992.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
![[UPDATED] Malaysia's health spending jumps 4 times in 20 years](/_next/image?url=https%3A%2F%2Fassets.nst.com.my%2Fimages%2Farticles%2FDzulkefly_Ahmadwe_1749435876.jpg&w=3840&q=100)
![[UPDATED] Malaysia's health spending jumps 4 times in 20 years](/_next/image?url=https%3A%2F%2Fassets.nst.com.my%2Fassets%2FNST-Logo%402x.png%3Fid%3Db37a17055cb1ffea01f5&w=48&q=75){kind=small}
New Straits Times
an hour ago
- New Straits Times
[UPDATED] Malaysia's health spending jumps 4 times in 20 years
KUALA LUMPUR: Malaysia's per capita health expenditure nearly quadrupled between 2000 and 2020. Health Minister Datuk Seri Dr Dzulkefly Ahmad said the figure surged from RM600 in 2000 to RM1,600 in 2020, driven by rising demand for healthcare and advances in medical technology. "Private sources accounted for RM40 billion, or 47 per cent, of total health expenditure in 2024. "Out-of-pocket spending remains high, at around 36 per cent of total health expenditure. "Our vision is to sustainably expand fiscal space while ensuring healthcare remains accessible, high-quality, and equitable," he said at the launch of the 31st Association of Private Hospitals Malaysia (APHM) International Healthcare Conference & Exhibition 2025, here, today. Dzulkefly said the Health Ministry was working with the Finance Ministry, Bank Negara Malaysia (BNM), and the Employees Provident Fund (EPF) to develop a health insurance and takaful product. This product will support the rollout of the new Diagnosis-Related Groups (DRGs) system, which aims to transform the way healthcare services are paid for. He also dismissed speculation of a delay in the DRG implementation, adding that the initiative remained on track to be introduced in phases by the end of this year, starting with the "Rakan KKM" project. "This is not privatisation. It is publicly owned and developed for public benefit, offering optional value-added services within the Health Ministry's hospitals. "We are already seeing proof-of-concept through the Hospital Service Outsourcing Programme (HSOP), which applies bundled payment principles. "For example, waiting times for arteriovenous (AV) fistula creation for haemodialysis patients have been reduced by over 75 per cent," he added. Turnaround times for Magnetic Resonance Imaging and Angiography (MRI/MRA) services have also improved by more than 20 per cent, Dzulkefly said, saying these value-based models demonstrated that system efficiency and clinical outcomes could be enhanced. Meanwhile, APHM president Datuk Dr Kuljit Singh highlighted the lack of a national electronic health record system, which he said was a critical gap in the DRG implementation process. "The absence of such a system makes DRG implementation more complex," he said. Nevertheless, he expressed appreciation for the ministry's commitment to collaboration and its data-driven, evidence-based approach to the DRG rollout.
The Star
2 hours ago
- The Star
Cabinet to decide on cannabis vape factory issue, says Health Minister
KUALA LUMPUR: The Cabinet will make a collective decision regarding the controversy surrounding a US-based vape company manufacturing "cannabis hardware" in Johor, says Health Minister Datuk Seri Dr Dzulkefly Ahmad. "I will address this issue later. We have to present it to the Cabinet and from there, we will make a collective decision," he said. He added that several ministries and agencies are involved, such as the Investment, Trade and Industry Ministry, the Malaysian Investment Development Authority among others. "So, we will table this in the Cabinet meeting and reach a collective decision," said Dr Dzulkefly after attending the opening ceremony of the 31st Association of Private Hospitals Malaysia (APHM) conference at the KL Convention Centre on Monday (June 9). On Thursday (June 5), Perikatan Nasional health committee chair Dr Ahmad Yunus Hairi called for a police investigation into the vape factory in Senai, Johor operated by Ispire Technology Inc, a Nasdaq-listed company based in California, US. "The manufacturing licence for Ispire's factory in Senai was issued by Mida. However, questions arose as to whether Mida approvals cover the manufacturing of cannabis-related products, which is clearly illegal under the Dangerous Drugs Act 1952," said the Kuala Langat MP. The licence granted by Mida to Ispire is touted as Malaysia's first federal licence to produce nicotine products. The sale of nicotine liquids is regulated under the Control of Smoking Products for Public Health Act.
Free Malaysia Today
2 hours ago
- Free Malaysia Today
Cabinet to decide on cannabis-linked vape production by US firm, says Dzulkefly
According to an investor presentation in Las Vegas in April, Ispire Technology Inc produces 'mainly cannabis-related products' in its Malaysian manufacturing facility. (LinkedIn pic) KUALA LUMPUR : The fate of a US-based vape manufacturer producing cannabis-related products in Malaysia will be decided by the Cabinet, says health minister Dzulkefly Ahmad. Speaking on the sidelines of the APHM International Healthcare Conference & Exhibition 2025, Dzulkefly said the issue involving Ispire Technology Inc would require the input of several ministries and government agencies. 'I will have to present (the matter) to the Cabinet. From there, we will decide on a stance. 'Several bodies are involved in this issue such as the investment, trade and industry ministry, the Malaysian Investment Development Authority, and the domestic trade and cost of living ministry,' he told reporters. Health think tank CodeBlue recently reported that Ispire, which produces nicotine and cannabis-related vaping products, had said that its devices were used by clients to fill cartridges with cannabis oils in global markets. According to an investor presentation in Las Vegas in April published on YouTube on May 6, Ispire produces 'mainly cannabis-related products' in its Malaysian manufacturing facility, which has up to seven production lines. In a statement last week, the health ministry confirmed that the government had issued Ispire an interim nicotine manufacturing licence to produce e-cigarettes with nicotine in its plant in Johor, together with local council approval. However, CodeBlue noted that the ministry's June 2 statement did not mention the plant's production of cannabis vaporisers, which reportedly began in February 2024. On June 5, Kuala Langat MP Dr Ahmad Yunus Hairi called for a police investigation into the vape factory's operations. GP consultation fee revision Separately, Dzulkefly said his ministry had submitted its plans to the National Action Council on Cost of Living to address the long-standing issue of revising general practitioner (GP) consultation fees. 'The council has requested that the matter be brought to its executive committee, which is chaired by deputy prime minister Ahmad Zahid Hamidi. 'There is no fixed date for discussions yet, but it will be soon,' he added. Yesterday, the Medical Practitioners Coalition Association of Malaysia (MPCAM) warned the government against deregulating GP consultation fees without setting a minimum rate. MPCAM president Dr Soo Tai Kang said such a move would lead to unhealthy competition in the industry, particularly in urban areas where 80% of GP clinics operate and depend heavily on panel patients. Soo said MPCAM supported setting consultation fees at between RM50 and RM80, with reviews every three years. On June 5, the Malaysian Medical Association called on the government to approve a long-pending increase in GP consultation fees, warning that delays threatened the survival of primary care clinics nationwide. Dzulkefly said on May 3 that the matter would be resolved 'within one month', and that a Cabinet memorandum and circular had already been prepared.
